Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - GeoVax Labs, Inc. | ex_234783.htm |
| EX-31.2 - EXHIBIT 31.2 - GeoVax Labs, Inc. | ex_234782.htm |
| EX-31.1 - EXHIBIT 31.1 - GeoVax Labs, Inc. | ex_234781.htm |
| EX-23.1 - EXHIBIT 23.1 - GeoVax Labs, Inc. | ex_235872.htm |
| EX-10.10 - EXHIBIT 10.10 - GeoVax Labs, Inc. | ex_234780.htm |
| EX-10.51 - EXHIBIT 10.5.1 - GeoVax Labs, Inc. | ex_234779.htm |
| 10-K - FORM 10-K - GeoVax Labs, Inc. | govx20201118_10k.htm |
Exhibit 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of GeoVax Labs, Inc. (the "Company") on Form 10-K for the year ended December 31, 2020, I, Mark W. Reynolds, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes - Oxley Act of 2002, that to the best of my knowledge:
|
1. |
The annual report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
|
2. |
The information contained in the annual report fairly presents, in all material respects, the financial condition and results of operations of the Company |
|
|
|
|
|
|
|
|
|
|
|
Dated: March 23, 2021 |
By: |
/s/ Mark W. Reynolds |
|
|
|
|
Mark W. Reynolds |
|
|
|
|
Chief Financial Officer |
|